GLP-1 and SGLT2 Users Face Different Risk for Diabetic Foot Complication
CHICAGO — Use of GLP-1 receptor agonists was tied to significantly lower risks of major diabetic foot complications compared with SGLT2 inhibitors in adults with type 2 diabetes, a large,…

